PATENT CLAIM ANALYSIS

Application Number: 15874659
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "190100"]

Abstract:
The present invention provides immunogens which can be used for vaccines against non-typeable  Haemophilus influenzae  (NTHi). The protein targeted is NTHi PDE1 and is highly conserved making it a vital component necessary for bacterial pathogenesis. The protein preferably includes the C terminal fragment after cleavage between Asn269 and Gly270, when compared to the wild-type PDE1 amino acid sequence. Nucleic acid sequences, amino acid sequences, immunogenic compositions, treatments and methods of diagnosis are disclosed.

Claim (Index 14):
The immunogenic composition of  claim 13 , further comprising an adjuvant.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.31746
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['09936362', '12336995', '11960883', '13005166', '14316935']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7375812362673895
- 35 USC 102 Novelty (BERT): 0.4944267280294097
- Combined Prediction Score: 0.7132657854435915
- Mean Citation Score: 272.78225000000003
- Max Citation Score: 279.99078
- Similarity Product: 250.768510010004

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test